Follow the 에이비프로바이오 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Industrials sector, 에이비프로바이오 has recorded 1 reports. Market capitalisation: €20.5bn. The latest transaction was reported on 16 March 2026 (Other). Among the most active insiders: 에이비프로바이오. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Established in the industrial sector, 에이비프로바이오 is listed on the XKRX market. The company specializes in the development of biopharmaceutical products.